OpenVSafe by OpenVAERS
Search V-safe

72X-26166-30875

3 vaccinations 5 coded responses 27 check-ins 5 free-text entries 0 call cases
Sex
Male
Age at first dose
31-35
ZIP prefix
209 / MD
Registered
2021-01-08
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-16
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-06
    Dose 2 — Pfizer-BioNTech
  3. 2021-01-08
    Registered in v-safe
  4. 2021-01-09
    Survey response — days 1–6 daily, dose 2
    MedDRA: Eye pain, Intraocular pressure test, Ocular discomfort, Pain — Feeling: Poor · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness
    Free text: Eye pain/intraoccular pressure, worse with movement
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-01-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache, Fatigue or tiredness
    Adult check-in
  6. 2021-01-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  7. 2021-01-13
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  8. 2021-01-21
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  9. 2021-01-27
    Health check-in — day 21, dose 2
    Feeling: Fair
    Adult check-in
  10. 2021-02-03
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  11. 2021-02-10
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-02-17
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-04-07
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-07-07
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-11-04
    Dose 3 — Moderna
  16. 2021-11-04
    Health check-in — day 0, dose 3
    Feeling: Good · None
    Adult check-in
  17. 2021-11-05
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  18. 2021-11-06
    Survey response — days 1–6 daily, dose 3
    MedDRA: Chest discomfort — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness
    Free text: Chest tightness
    MedDRA releases: 2024-11 · check-in free text available
  19. 2021-11-07
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Fatigue or tiredness
    Adult check-in
  20. 2021-11-08
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness
    Adult check-in
  21. 2021-11-09
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  22. 2021-11-10
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  23. 2021-11-11
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  24. 2021-11-18
    Survey response — day 14, dose 3
    MedDRA: Body temperature increased, Chills, Headache, Myalgia, SARS-CoV-2 test negative — Feeling: Good
    Free text: Had returned to baseline a few days post-vaccination booster. Then 2 days ago had headache, chills, myalgia, and low-grade fever (99-100.3 range). Negative antigen COVID test. Back to baseline today.
    MedDRA releases: 2024-11 · check-in free text available
  25. 2021-11-25
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  26. 2021-12-02
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  27. 2021-12-09
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  28. 2021-12-16
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  29. 2022-02-03
    Survey response — 3 months, dose 3
    MedDRA: Chills, Headache, Myalgia, Nausea, SARS-CoV-2 test negative — Feeling: Fair · Be unable to work or attend school
    Free text: Headache, chills, myalgia, nausea. Had a negative rapid antigen COVID test and a negative PCR COVID test, so probably something else.
    MedDRA releases: 2024-11 · check-in free text available
  30. 2022-05-05
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  31. 2022-11-04
    Survey response — 12 months, dose 3
    MedDRA: Chest pain — Feeling: Good
    Free text: Had some chest pains that would come and go
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12020-12-16Pfizer-BioNTech
22021-01-06Pfizer-BioNTech
32021-11-04Moderna No

Free text

Release 1 — days 1–6 daily, dose 2

2021-01-09

Systemic reaction (other): Eye pain/intraoccular pressure, worse with movement

Release 10 — days 1–6 daily, dose 3

2021-11-06

Systemic reaction (other): Chest tightness

Release 10 — day 14, dose 3

2021-11-18

Symptoms: Had returned to baseline a few days post-vaccination booster. Then 2 days ago had headache, chills, myalgia, and low-grade fever (99-100.3 range). Negative antigen COVID test. Back to baseline today.

Release 11 — 3 months, dose 3

2022-02-03

Symptoms: Headache, chills, myalgia, nausea. Had a negative rapid antigen COVID test and a negative PCR COVID test, so probably something else.

Release 12 — 12 months, dose 3

2022-11-04

Symptoms: Had some chest pains that would come and go

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDBody temperature increased · · ✓
SDChest pain · · ✓
SDChills · · ✓
SDHeadache · · ✓
SDMyalgia · · ✓
SDNausea · · ✓
SDSARS-CoV-2 test negative · · ✓
SROChest discomfort · · ✓
SROEye pain ✓ ✓ ✓
SROIntraocular pressure test ○ ✓ ○
SROOcular discomfort ✓ · ✓
SROPain ✓ · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release